Protein engineering is defined as the process for the development of new proteins through directed evaluation and rational protein designing, which can be used as therapeutic agents. Globally, development the arena of proteomics and nanotechnology, rising incidences of chronic and autoimmune diseases, rise in the awareness among people regarding protein engineering, increasing focus on research and development process, development in drug delivery system, and rise in adoption of protein-based drugs over non-protein-based drugs are the prime growth drivers of protein engineering market. In addition, rising popularity of protein therapy as an alternative to gene therapy, increase in adoption of protein engineering in emerging economies such as China, India and others, will create new opportunities for protein engineering market. However, higher cost of the research and development, higher cost of tools and instruments used in protein engineering and its maintenance, and complex government approval processes are the key restraints for protein engineering market.













